NCT07111884

GMMG Multiple Myeloma Registry

Recruiting · Not specified · Prof. Dr. Hartmut Goldschmidt · registry updated 2025-08-08

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are: Overall survival, progression-free survival and follow-up time. The relevant registry data will be provided and evaluated together with the therapy study data for scientific research projects. This allows seamless documentation of patient data from the end of the trial to long-term follow-up.

Inclusion

Previous participation in a a therapy study of the GMMG study group

Exclusion

patients with organ amyloidosis at time of diagnosis

Open NCT07111884 on ClinicalTrials.gov All conditions